Somatostatin analogues are commonly used to treat symptoms associated with hormone hypersecretion in neuroendocrine tumors; however, data on their antitumor effects are limited.

Caplin, M., Pavel, M., Ćwikła, J., Phan, A., Raderer, M., Sedláčková, E., Cadiot, G., Wolin, E., Capdevila, J., Wall, L., Rindi, G., Langley, A., Martinez, S., Blumberg, J., Ruszniewski, P., Lanreotide in metastatic enteropancreatic neuroendocrine tumors, <<NEW ENGLAND JOURNAL OF MEDICINE>>, 2014; 371 (3): 224-233. [doi:10.1056/NEJMoa1316158] [http://hdl.handle.net/10807/64266]

Lanreotide in metastatic enteropancreatic neuroendocrine tumors

Rindi, Guido;
2014

Abstract

Somatostatin analogues are commonly used to treat symptoms associated with hormone hypersecretion in neuroendocrine tumors; however, data on their antitumor effects are limited.
2014
Inglese
Caplin, M., Pavel, M., Ćwikła, J., Phan, A., Raderer, M., Sedláčková, E., Cadiot, G., Wolin, E., Capdevila, J., Wall, L., Rindi, G., Langley, A., Martinez, S., Blumberg, J., Ruszniewski, P., Lanreotide in metastatic enteropancreatic neuroendocrine tumors, <<NEW ENGLAND JOURNAL OF MEDICINE>>, 2014; 371 (3): 224-233. [doi:10.1056/NEJMoa1316158] [http://hdl.handle.net/10807/64266]
File in questo prodotto:
Non ci sono file associati a questo prodotto.

I documenti in IRIS sono protetti da copyright e tutti i diritti sono riservati, salvo diversa indicazione.

Utilizza questo identificativo per citare o creare un link a questo documento: https://hdl.handle.net/10807/64266
Citazioni
  • ???jsp.display-item.citation.pmc??? 472
  • Scopus 932
  • ???jsp.display-item.citation.isi??? 1282
social impact